Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD

RATIONALE: The purpose of this study was to investigate the clinical efficacy and safety of a fixed-dose combination of mometasone furoate/formoterol fumarate (MF/F) administered via a metered-dose inhaler in subjects with moderate-to-very severe chronic obstructive pulmonary disease (COPD). METHODS...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Doherty, Dennis E, Tashkin, Donald P, Kerwin, Edward, Knorr, Barbara A, Shekar, Tulin, Banerjee, Sibabrata, Staudinger, Heribert
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2012
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3276257/
https://ncbi.nlm.nih.gov/pubmed/22334769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S27320
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados